Clinical Trials Logo

Clinical Trial Summary

In the course of COVID disease, some patients need intensive care treatment. We aim to find an answer to the question of whether the patient's CRP, ferritin, D-dimer, Oxygen Saturation, lymphocyte count, and body mass index can be used as a criterion for admitting patients with COVID to the intensive see unit.


Clinical Trial Description

It is aimed to determine the patients who are above the threshold value to be determined according to this scoring result. Identifying patients who may need intensive care and following them closely will positively affect patient prognosis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04383483
Study type Observational
Source Bursa Yüksek Ihtisas Education and Research Hospital
Contact Ali Asan, MD
Phone +905332401067
Email draasan@yahoo.com
Status Recruiting
Phase
Start date June 15, 2020
Completion date February 28, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04348370 - BCG Vaccine for Health Care Workers as Defense Against COVID 19 Phase 4
Terminated NCT04369989 - Observational Study of COVID-19 Treatment Efficacy